These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11915367)

  • 1. Chronic toxicity in monkeys with the thiazolidinedione antidiabetic agent troglitazone.
    Rothwell C; McGuire EJ; Altrogge DM; Masuda H; de la Iglesia FA
    J Toxicol Sci; 2002 Feb; 27(1):35-47. PubMed ID: 11915367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone.
    Herman JR; Dethloff LA; McGuire EJ; Parker RF; Walsh KM; Gough AW; Masuda H; de la Iglesia FA
    Toxicol Sci; 2002 Jul; 68(1):226-36. PubMed ID: 12075125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.
    Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K
    Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.
    Kassahun K; Pearson PG; Tang W; McIntosh I; Leung K; Elmore C; Dean D; Wang R; Doss G; Baillie TA
    Chem Res Toxicol; 2001 Jan; 14(1):62-70. PubMed ID: 11170509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
    Bristol DW
    Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose study.
    Loi CM; Randinitis EJ; Vassos AB; Kazierad DJ; Koup JR; Sedman AJ
    J Clin Pharmacol; 1997 Dec; 37(12):1114-20. PubMed ID: 9506006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
    Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
    Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.
    Izumi T; Enomoto S; Hosiyama K; Sasahara K; Shibukawa A; Nakagawa T; Sugiyama Y
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1630-41. PubMed ID: 8667232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
    Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of troglitazone.
    Loi CM; Young M; Randinitis E; Vassos A; Koup JR
    Clin Pharmacokinet; 1999 Aug; 37(2):91-104. PubMed ID: 10496299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients.
    Young MA; Eckland DJ; Eastmond R; Lettis S
    Ann Med; 1998 Apr; 30(2):206-12. PubMed ID: 9667800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo.
    Tettey JN; Maggs JL; Rapeport WG; Pirmohamed M; Park BK
    Chem Res Toxicol; 2001 Aug; 14(8):965-74. PubMed ID: 11511170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats.
    Michels GM; Boudinot FD; Ferguson DC; Hoenig M
    Am J Vet Res; 2000 Jul; 61(7):775-8. PubMed ID: 10895899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of steady-state pharmacokinetics of troglitazone and its metabolites.
    Loi CM; Alvey CW; Randinitis EJ; Abel R; Young MA; Koup JR
    J Clin Pharmacol; 1997 Nov; 37(11):1038-47. PubMed ID: 9505997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on hindered phenols and analogues. V. Synthesis, identification, and antidiabetic activity of the glucuronide of CS-045.
    Yoshioka T; Aizawa Y; Fujita T; Nakamura K; Sasahara K; Kuwano H; Kinoshita T; Horikoshi H
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2124-5. PubMed ID: 1797433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells.
    Yamamoto Y; Nakajima M; Yamazaki H; Yokoi T
    Life Sci; 2001 Dec; 70(4):471-82. PubMed ID: 11798015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.